Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Colorectal cancer (CRC) is one of the leading cancers in terms of prevalence and mortality. Almost 1/4 of patients with CRC have metastases at the initial presentation. The survival rate of this group of patients remains low. With the onset of the COVID-19 pandemic, cancer patients have faced diffic...

Full description

Bibliographic Details
Main Authors: Marina I. Sekacheva, Anastasia S. Fatyanova, Daur A. Meretukov, Angelina V Zhilenkova, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasiia A. Guryanova, Nikolay N. Bagmet
Format: Article
Language:Russian
Published: IP Habib O.N. 2021-08-01
Series:Современная онкология
Subjects:
colorectal cancer
covid-19
chemotherapy
targeted therapy
regorafenib
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/71019/pdf

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/71019/pdf

Similar Items